Share About DuPont Industrial Biosciences DuPont Industrial Biosciences works with customers across a wide range of industries to make products and industrial processes more efficient and sustainable.
Liveris will be named Executive Chairman and Edward D. DOW today announced that their boards of directors unanimously approved a definitive agreement under which the companies will combine in an all-stock merger of equals. The combined company will be named DowDuPont.
The parties intend to subsequently pursue a separation of DowDuPont into three independent, publicly traded companies through tax-free spin-offs. This would occur as soon as feasible, which is expected to be months following the closing of the merger, subject to regulatory and board approval. The companies will include a leading global pure-play Agriculture company; a leading global pure-play Material Science company; and a leading technology and innovation-driven Specialty Products company.
Each of the businesses will have clear focus, an appropriate capital structure, a distinct and compelling investment thesis, scale advantages, and focused investments in innovation to better deliver superior solutions and choices for customers.
This merger of equals significantly enhances the growth profile for both companies, while driving value for all of our shareholders and our customers. Breen, chairman and chief executive officer of DuPont.
This merger of equals will create significant near-term value through substantial cost synergies and additional upside from growth synergies. Under the terms of the transaction, Dow shareholders will receive a fixed exchange ratio of 1. Dow and DuPont shareholders will each own approximately 50 percent of the combined company, on a fully diluted basis, excluding preferred shares.
Each would be a strong, focused business with powerful innovation capabilities, enhanced global scale and product portfolios, focused capital allocation, and a distinct competitive position.
The three businesses that the boards intend to separate are: The combined entity will have the most comprehensive and diverse portfolio and a robust pipeline with exceptional growth opportunities in the near- mid- and long-term.
The complementary offerings of the two companies will provide growers across geographies with a broad portfolio of solutions and greater choice.
The combination of complementary capabilities will create a low-cost, innovation-driven leader that can provide customers in high-growth, high-value industry segments in packaging, transportation, and infrastructure solutions, among others with a broad and deep portfolio of cost-effective offerings.
A technology driven innovative leader, focused on unique businesses that share similar investment characteristics and specialty market focus. Together, their complementary offerings create a new global leader in Electronics Products, and each business will benefit from more targeted investment in their productive technology development and innovation capabilities.
Advisory Committees will be established for each of the businesses. These Committees will oversee the respective businesses, and will work with Liveris and Breen on the intended separation of the businesses into independent, standalone entities.
In these roles, both Liveris and Breen will report to the Board of Directors. In addition, when named, the chief financial officer will report to Breen. The full list of directors will be announced prior to or in conjunction with the closing of the merger.Company Overview From their innovative products to their large global involvement, PepsiCo is a company that is constantly growing and shaping the industry.
It is a leading food and beverage company that operates as a manufacturing service as it makes it’s own products and distributes them. Some of the key players in this market are BASF SE, Dow Chemical Company, Huntsman Corporation, Nippon Kayaku Company, Cabot Corporation, Clariant, Sensient Technologies, Synthesia, Shanghai Road Dyestuffs & Chemicals, Evonik Degussa, Ei Dupont De Nemours, Dic Corporation and others.
Learn what its like to work for DuPont Company (Singapore) Pte Ltd by reading employee ratings and reviews on schwenkreis.com Singapore. Considering a career at DuPont Company (Singapore) Pte Ltd?
Company overview. (NYSE: DWDP) is a holding company comprised of The Dow Chemical Company and DuPont with the intent to form strong. Microsoft Corporation.
Contacts. Reach the right people with access to detailed contact information. Corporate Relations.
Get the big picture on a company's affiliates and who they do business with. Close Industry Peers.
See similar companies for insight and prospecting. Bayer is a Life Science company with a more than year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
Seed Treatment Fungicides Market report offers an overview of the market trends, drivers, Syngenta, Dow Chemical Company, DuPont, Nufarm, Monsanto Company, FMC Corporation, Novozymes, Platform Specialty Products.